Assurance Services
Tax Consulting
Consulting Services340B Consulting
Our team of 340B Apexus Certified Experts can assist your covered entity with everything from implementation and compliance to revenue optimization. See our detailed services list below.
Interested in receiving quarterly news and updates based on relevant 340B topics? If so, you can subscribe (and see what other newsletters we have) here.
Services Overview
Compliance Services
As HRSA continues to scrutinize the program and increase the number of audits it performs, we can assist you in navigating the compliance requirements. Our services include:
- Policies and Procedures review
- Quarterly compliance monitoring
- Annual compliance audits
- HRSA audit preparation and on-site assistance
- Patient definition review
- Medicaid duplicate discount review
- Staff education and training
- Third-party system review and selection
- New implementation guidance
- IT data extracts and transfer
Revenue Optimization
We can assist you in making sure that you are receiving the optimal financial benefit from the 340B Program relative to the inherent compliance risks of participating in the program.
We are offering a Complimentary Financial Analysis of your 340B Retail Pharmacy Program. If you would like one of our 340B consultants to analyze your retail program for possible revenue opportunities, feel free to contact us.
340B Implementation Assistance
- Provider-Based location development
- Revenue analysis
- Medicare cost report compilation
- Contract pharmacy negotiation
- 340B software selection
- HRSA registration
- Program monitoring
Related Articles View All Thought Leadership
January 13, 2026
The deadline for hospitals to submit the Occupational Mix Survey is June 30, 2026. The Centers for Medicare and Medicaid Services (CMS) collects this data every three years on the […]
January 13, 2026
Outsourcing is a common practice in all areas of business, including the healthcare sector. Although this is a major expense for a hospital, it can influence the wage index factor […]
January 12, 2026
The Centers for Medicare & Medicaid Services (CMS) Low Volume Payment Adjustment attestation period has been extended. Congress recently passed a short-term temporary extension, extending the deadline to January 30, […]
Connect with our team.
To learn more about our services and areas of expertise, send us a message.
Kristina Lakins’ experience highlights the commitment Blue & Co. makes to developing strong, thoughtful leaders. Through Blue’s first ACCELERATE! cohort, Kristina is sharpening her leadership and strategic skills while growing as a manager. We appreciate Kristina for embracing this opportunity and exemplifying a passion for continuous growth.![]()
![]()
![]()
![]()
![]()
![]()
To learn more about what makes Blue & Co. such a great place to work, head to hubs.la/Q03Y99Ft0.
As the dental industry continues to learn the vernacular of dental service organizations, one financial term has taken center stage: EBITDA. While EBITDA is often touted as a key indicator of practice value or practice performance, it is frequently misunderstood and misapplied. In this article, Blue & Co. experts break down what EBITDA really means, why normalized compensation matters, and how these figures can influence practice ownership, valuations, and the way you evaluate your Practice. Before you rely on EBITDA alone, discover its uses, limitations, and why it should be just one tool in your financial toolkit.![]()
![]()
![]()
![]()
![]()
![]()
Read the full article:
Quick Links
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.